U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602062) titled 'Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis' on April 25.
Brief Summary: This study aims to explore the safety and efficacy of oral administration of a novel anticoagulant (rivaroxaban) in patients with cirrhosis accompanied by high-risk esophagogastric variceal bleeding and portal vein thrombosis, through a prospective, multicenter, randomized controlled clinical trial, starting 48 hours after endoscopic treatment to prevent rebleeding.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Portal Vein Thrombosis
Anticoagulant Therapy
Varicea...